One Global Service Provider Ltd., a Mumbai-based healthcare services company, has delivered extraordinary returns over the last five years, with its stock rising from around ₹2 in January 2021 to nearly ₹665.
The rally translates into a gain of about 33,150 percent. An investment of ₹1 lakh at the beginning of 2021 would now be worth roughly ₹3.3 crore.
At the stock’s all-time high of ₹790, the same investment would have grown to nearly ₹3.95 crore.
Business transformation
Incorporated in 1992, the company was previously known as Overseas Synthetics Limited.
It now operates under the 1Global brand and provides healthcare and life sciences solutions across global markets.
Its operations cover:
- Mass screening
- Diagnostics
- Healthcare sciences
The company serves hospitals and institutional clients and focuses on end-to-end healthcare solutions.
Revenue growth accelerates
The biggest change has come in the scale of operations.
Revenue from operations increased from ₹4 crore in FY21 to ₹498 crore in FY26, representing growth of more than 12,000 percent over five years.
Operating profit also rose sharply.
FY21 vs FY26
| Particulars | FY21 | FY26 |
|---|---|---|
| Revenue from operations | ₹4 crore | ₹498 crore |
| Operating profit | ₹2 crore | ₹93 crore |
| Net profit | ₹2 crore | ₹70 crore |
| Operating margin | 17% | 19% |
Net profit increased from ₹2 crore in FY21 to ₹70 crore in FY26.
Strong growth in FY26
The company reported a sharp jump in earnings during FY26.
Compared with FY25:
- Revenue increased from ₹147 crore to ₹498 crore.
- Operating profit rose from ₹25 crore to ₹93 crore.
- Operating margins improved from 17 percent to 19 percent.
- Net profit climbed from ₹18 crore to ₹70 crore.
The figures indicate a significant improvement in both scale and profitability.
Debt remains negligible
Unlike many rapidly expanding companies, One Global Service Provider has grown without taking on substantial debt.
As of March 2026:
- Long-term borrowings stood at ₹0.03 crore.
- Total equity increased from ₹71.72 crore to ₹141.23 crore.
- Reserves and surplus rose from ₹52.18 crore to ₹121.69 crore.
Trade receivables increased sharply during the year, rising from ₹57.65 crore to ₹216.58 crore, a metric investors may continue to monitor.
The company received an unmodified audit opinion.
Dividend announced
The board has recommended a final dividend of ₹1 per share for FY26.
The payout represents 10 percent of the face value of ₹10.
About the company
One Global Service Provider Ltd., listed on the BSE under scrip code 514330, operates in the healthcare services space.
Formerly known as Overseas Synthetics Limited, the company provides life sciences and healthcare solutions to hospitals and institutions worldwide.
TL;DR:
One Global Service Provider’s stock has climbed from ₹2 to ₹665 in five years, turning ₹1 lakh into about ₹3.3 crore. The rally has been accompanied by strong growth in revenue and profit, while the company has maintained a virtually debt-free balance sheet.
AI Summary:
- One Global Service Provider shares have surged over 33,000% in five years.
- Revenue grew from ₹4 crore in FY21 to ₹498 crore in FY26.
- Net profit increased to ₹70 crore from ₹2 crore over the same period.
- Long-term borrowings stood at only ₹0.03 crore.
- The board recommended a dividend of ₹1 per share.
